[1]
|
Shimony, S., Stahl, M. and Stone, R.M. (2023) Acute Myeloid Leukemia: 2023 Update on Diagnosis, Risk-Stratifica-tion, and Management. American Journal of Hematology, 98, 502-526. https://doi.org/10.1002/ajh.26822
|
[2]
|
Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1985) Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia. A Report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 620-625. https://doi.org/10.7326/0003-4819-103-4-620
|
[3]
|
Arber, D.A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M.J., Le Beau, M.M., Bloomfield, C.D., Cazzola, M. and Vardiman, J.W. (2016) The 2016 Revision to the World Health Organization Classification of Myeloid Neoplasms and Acute Leukemia. Blood, 127, 2391-2405. https://doi.org/10.1182/blood-2016-03-643544
|
[4]
|
Hou, H.A. and Tien, H.F. (2020) Genomic Landscape in Acute Myeloid Leukemia and Its Implications in Risk Classification and Targeted Therapies. Journal of Biomedical Science, 27, Article No. 81. https://doi.org/10.1186/s12929-020-00674-7
|
[5]
|
Khwaja, A., Bjorkholm, M., Gale, R.E., Levine, R.L., Jordan, C.T., Ehninger, G., Bloomfield, C.D., Estey, E., Burnett, A., Cornelissen, J.J., Scheinberg, D.A., Bouscary, D. and Linch, D.C. (2016) Acute Myeloid Leukaemia. Nature Reviews Disease Primers, 2, Article No. 16010. https://doi.org/10.1038/nrdp.2016.10
|
[6]
|
Liu H. (2021) Emerging Agents and Regimens for AML. Journal of Hematology & Oncology, 14, Article No. 49. https://doi.org/10.1186/s13045-021-01062-w
|
[7]
|
Zebisch, A., Hatzl, S., Pichler, M., Wölfler, A. and Sill, H. (2016) Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs. International Journal of Molecular Sciences, 17, Article 2080. https://doi.org/10.3390/ijms17122080
|
[8]
|
Li, M.H., Fu, S.B. and Xiao, H.S. (2015) Genome-Wide Analysis of MicroRNA and MRNA Expression Signatures in Cancer. Acta Pharmacologica Sinica, 36, 1200-1211. https://doi.org/10.1038/aps.2015.67
|
[9]
|
Liu, Y., Cheng, Z., Pang, Y., Cui, L., Qian, T., Quan, L., Zhao, H., Shi, J., Ke, X. and Fu, L. (2019) Role of MicroRNAs, CircRNAs and Long Noncoding RNAs in Acute Myeloid Leukemia. Journal of Hematology & Oncology, 12, Article No. 51. https://doi.org/10.1186/s13045-019-0734-5
|
[10]
|
(2022) The Expanding World of Noncoding RNA Biology. Nature Cell Biology, 24, 1447. https://doi.org/10.1038/s41556-022-01016-5
|
[11]
|
Wang, Y., Gong, G., Xu, J., Zhang, Y., Wu, S. and Wang, S. (2020) Long Noncoding RNA HOTAIR Promotes Breast Cancer Development by Targeting ZEB1 via Sponging MiR-601. Cancer Cell International, 20, Article No. 320. https://doi.org/10.1186/s12935-020-01410-9
|
[12]
|
Spahn, M., Kneitz, S., Scholz, C.J., Stenger, N., Rüdiger, T., Ströbel, P., Riedmiller, H. and Kneitz, B. (2010) Expression of MicroRNA-221 Is Progressively Reduced in Aggressive Prostate Cancer and Metastasis and Predicts Clinical Recurrence. International Journal of Cancer, 127, 394-403. https://doi.org/10.1002/ijc.24715
|
[13]
|
Toden, S., Zumwalt, T.J. and Goel, A. (2021) Non-Coding RNAs and Potential Therapeutic Targeting in Cancer. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1875, Article ID: 188491. https://doi.org/10.1016/j.bbcan.2020.188491
|
[14]
|
Bartel, D.P. (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell, 116, 281-297. https://doi.org/10.1016/S0092-8674(04)00045-5
|
[15]
|
Garzon, R., Calin, G.A. and Croce, C.M. (2009) MicroRNAs in Cancer. Annual Review of Medicine, 60, 167-179. https://doi.org/10.1146/annurev.med.59.053006.104707
|
[16]
|
Dixon-McIver, A., East, P., Mein, C.A., Cazier, J.B., Molloy, G., Chaplin, T., Andrew, Lister, T., Young, B.D. and Debernardi, S. (2008) Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia. PLOS ONE, 3, e2141. https://doi.org/10.1371/journal.pone.0002141
|
[17]
|
Garzon, R., Volinia, S., Liu, C.G., Fernandez-Cymering, C., Palumbo, T., Pichiorri, F., Fabbri, M., Coombes, K., Alder, H., Nakamura, T., Flomenberg, N., Marcucci, G., Calin, G.A., Kornblau, S.M., Kantarjian, H., Bloomfield, C.D., Andreeff, M. and Croce, C.M. (2008) MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia. Blood, 111, 3183-3189. https://doi.org/10.1182/blood-2007-07-098749
|
[18]
|
Bhayadia, R., Krowiorz, K., Haetscher, N., Jammal, R., Emmrich, S., Obulkasim, A., Fiedler, J., Schwarzer, A., Rouhi, A., Heuser, M., Wingert, S., Bothur, S., Döhner, K., Mätzig, T., Ng, M., Reinhardt, D., Döhner, H., Zwaan, C.M., Van Den Heuvel Eibrink, M., Heckl, D., Fornerod, M., Thum, T., Humphries, R.K., Rieger, M.A., Kuchenbauer, F. and Klusmann, J.H. (2018) Endogenous Tumor Suppressor MicroRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. Journal of Clinical Oncology, 36, 1007-1016. https://doi.org/10.1200/JCO.2017.75.2204
|
[19]
|
Gao, X.N., Lin, J., Gao, L., Li, Y.H., Wang, L.L. and Yu, L. (2011) MicroRNA-193b Regulates C-Kit Proto-Oncogene and Represses Cell Proliferation in Acute Myeloid Leukemia. Leukemia Research, 35, 1226-1232. https://doi.org/10.1016/j.leukres.2011.06.010
|
[20]
|
Guo, Y., Strickland, S.A., Mohan, S., Li, S., Bosompem, A., Vickers, K.C., Zhao, S., Sheng, Q. and Kim, A.S. (2017) MicroRNAs and TRNA-Derived Fragments Predict the Transformation of Myelodysplastic Syndromes to Acute Myeloid Leukemia. Leukemia & Lymphoma, 58, 2144-2155. https://doi.org/10.1080/10428194.2016.1272680
|
[21]
|
Lim, E.L., Trinh, D.L., Ries, R.E., Wang, J., Gerbing, R.B., Ma, Y., Topham, J., Hughes, M., Pleasance, E., Mungall, A.J., Moore, R., Zhao, Y., Aplenc, R., Sung, L., Kolb, E.A., Gamis, A., Smith, M., Gerhard, D.S., Alonzo, T.A., Meshinchi, S. and Marra, M.A. (2017) MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia. Journal of Clinical Oncology, 35, 3964-3977. https://doi.org/10.1200/JCO.2017.74.7451
|
[22]
|
Li, H., Hui, L. and Xu, W. (2012) MiR-181a Sensitizes a Multidrug-Resistant Leukemia Cell Line K562/A02 to Daunorubicin by Targeting BCL-2. Acta Biochimica et Biophysica Sinica, 44, 269-277. https://doi.org/10.1093/abbs/gmr128
|
[23]
|
Zhang, S., Zhang, Q., Shi, G. and Yin, J. (2018) MiR-182-5p Regulates BCL2L12 and BCL2 Expression in Acute Myeloid Leukemia as a Potential Therapeutic Target. Biomedicine & Pharmacotherapy, 97, 1189-1194. https://doi.org/10.1016/j.biopha.2017.11.002
|
[24]
|
Gourvest, M., Brousset, P. and Bousquet, M. (2019) Long Noncoding RNAs in Acute Myeloid Leukemia: Functional Characterization and Clinical Relevance. Cancers, 11, Article 1638. https://doi.org/10.3390/cancers11111638
|
[25]
|
Mishra, S., Liu, J., Chai, L. and Tenen, D.G. (2022) Diverse Functions of Long Noncoding RNAs in Acute Myeloid Leukemia: Emerging Roles in Pathophysiology, Prognosis, and Treatment Resistance. Current Opinion in Hematology, 29, 34-43. https://doi.org/10.1097/MOH.0000000000000692
|
[26]
|
Tsai, C.H., Yao, C.Y., Tien, F.M., Tang, J.L., Kuo, Y.Y., Chiu, Y.C., Lin, C.C., Tseng, M.H., Peng, Y.L., Liu, M.C., Liu, C.W., Yao, M., Lin, L.I., Chou, W.C., Chen, C.Y., Hou, H.A. and Tien, H.F. (2019) Incorporation of Long Non-Coding RNA Expression Profile in the 2017 ELN Risk Classification Can Improve Prognostic Prediction of Acute Myeloid Leukemia Patients. eBioMedicine, 40, 240-250. https://doi.org/10.1016/j.ebiom.2019.01.022
|
[27]
|
Buono, L., Iside, C., De Matteo, A., Stellato, P., Beneduce, G., De Vera D’Aragona, R.P., Parasole, R., Salvatore, M., Smaldone, G. and Mirabelli, P. (2022) Specific LncRNA Signatures Discriminate Childhood Acute Leukaemias: A Pilot Study. Cancer Cell International, 22, Article No. 373. https://doi.org/10.1186/s12935-022-02789-3
|
[28]
|
Yang, L., Zhou, J.D., Zhang, T.J., Ma, J.C., Xiao, G.F., Chen, Q., Deng, Z.Q., Lin, J., Qian, J. and Yao, D.M. (2018) Overexpression of LncRNA PANDAR Predicts Adverse Prognosis in Acute Myeloid Leukemia. Cancer Management and Research, 10, 4999-5007. https://doi.org/10.2147/CMAR.S180150
|
[29]
|
Wang, Y., Li, Y., Song, H.Q. and Sun, G.W. (2018) Long Non-Coding RNA LINC00899 as a Novel Serum Biomarker for Diagnosis and Prognosis Prediction of Acute Myeloid Leukemia. European Review for Medical and Pharmacological Sciences, 22, 7364-7370.
|
[30]
|
Farrar, J.E., Smith, J.L., Othus, M., Huang, B.J., Wang, Y.C., Ries, R., Hylkema, T., Pogosova-Agadjanyan, E.L., Challa, S., Leonti, A., Shaw, T.I., Triche Jr., T.J., Gamis, A.S., Aplenc, R., Kolb, E.A., Ma, X., Stirewalt, D.L., Alonzo, T.A. and Meshinchi, S. (2023) Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia. Journal of Clinical Oncology, 41, 2949-2962. https://doi.org/10.1200/JCO.22.01114
|
[31]
|
Yu, Y., Kou, D., Liu, B., Huang, Y., Li, S., Qi, Y., Guo, Y., Huang, T., Qi, X. and Jia, L. (2020) LncRNA MEG3 Contributes to Drug Resistance in Acute Myeloid Leukemia by Positively Regulating ALG9 through Sponging MiR-155. International Journal of Laboratory Hematology, 42, 464-472. https://doi.org/10.1111/ijlh.13225
|
[32]
|
Kirtonia, A., Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Zabolian, A., Bejandi, A.K., Rani, R., Pandey, A.K., Baligar, P., Kumar, V., Das, B.C. and Garg, M. (2022) Long Noncoding RNAs: A Novel Insight in the Leukemogenesis and Drug Resistance in Acute Myeloid Leukemia. Journal of Cellular Physiology, 237, 450-465. https://doi.org/10.1002/jcp.30590
|
[33]
|
Izadirad, M., Jafari, L., James, A.R., Unfried, J.P., Wu, Z.X. and Chen, Z.S. (2021) Long Noncoding RNAs Have Pivotal Roles in Chemoresistance of Acute Myeloid Leukemia. Drug Discovery Today, 26, 1735-1743. https://doi.org/10.1016/j.drudis.2021.03.017
|
[34]
|
Zhou, M., Gao, X., Zheng, X. and Luo, J. (2022) Functions and Clinical Significance of Circular RNAs in Acute Myeloid Leukemia. Frontiers in Pharmacology, 13, Article 1010579. https://doi.org/10.3389/fphar.2022.1010579
|
[35]
|
Papaioannou, D., Volinia, S., Nicolet, D., Świerniak, M., Petri, A., Mrózek, K., Bill, M., Pepe, F., Walker, C.J., Walker, A.E., Carroll, A.J., Kohlschmidt, J., Eisfeld, A.K., Powell, B.L., Uy, G.L., Kolitz, J.E., Wang, E.S., Kauppinen, S., Dorrance, A., Stone, R.M., Byrd, J.C., Bloomfield, C.D. and Garzon, R. (2020) Clinical and Functional Significance of Circular RNAs in Cytogenetically Normal AML. Blood Advances, 4, 239-251. https://doi.org/10.1182/bloodadvances.2019000568
|
[36]
|
Lux, S., Blätte, T.J., Gillissen, B., Richter, A., Cocciardi, S., Skambraks, S., Schwarz, K., Schrezenmeier, H., Döhner, H., Döhner, K., Dolnik, A. and Bullinger, L. (2021) Deregulated Expression of Circular RNAs in Acute Myeloid Leukemia. Blood Advances, 5, 1490-1503. https://doi.org/10.1182/bloodadvances.2020003230
|
[37]
|
Li, W., Zhong, C., Jiao, J., Li, P., Cui, B., Ji, C. and Ma, D. (2017) Characterization of Hsa_Circ_0004277 as a New Biomarker for Acute Myeloid Leukemia via Circular RNA Profile and Bioinformatics Analysis. International Journal of Molecular Sciences, 18, Article 597. https://doi.org/10.3390/ijms18030597
|
[38]
|
Wang, J., Pan, J., Huang, S., Li, F., Huang, J., Li, X., Ling, Q., Ye, W., Wang, Y., Yu, W. and Jin, J. (2021) Development and Validation of a Novel Circular RNA as an Independent Prognostic Factor in Acute Myeloid Leukemia. BMC Medicine, 19, Article No. 28. https://doi.org/10.1186/s12916-020-01898-y
|
[39]
|
Lei, P., Chen, J.J., Liao, C.S., Liu, G.H. and Zhou, M. (2019) Silencing of Circ_0009910 Inhibits Acute Myeloid Leukemia Cell Growth through Increasing MiR-20a-5p. Blood Cells, Molecules, and Diseases, 75, 41-47. https://doi.org/10.1016/j.bcmd.2018.12.006
|
[40]
|
Shang, J., Chen, W.M., Wang, Z.H., Wei, T.N., Chen, Z.Z. and Wu, W.B. (2019) CircPAN3 Mediates Drug Resistance in Acute Myeloid Leukemia through the MiR-153-5p/MiR-183-5p-XIAP Axis. Experimental Hematology, 70, 42-54.E3. https://doi.org/10.1016/j.exphem.2018.10.011
|
[41]
|
Teittinen, K.J., Laiho, A., Uusimäki, A., Pursiheimo, J.P., Gyenesei, A. and Lohi, O. (2013) Expression of Small Nucleolar RNAs in Leukemic Cells. Cellular Oncology, 36, 55-63. https://doi.org/10.1007/s13402-012-0113-5
|
[42]
|
Ghaseminezhad, Z., Sharifi, M., Bahreini, A., et al. (2022) Investigation of the Expression of P-Element-Induced Wimpy Testis-Interacting RNAs in Human Acute Myeloid Leukemia. Meta Gene, 31, Article ID: 100998. https://doi.org/10.1016/j.mgene.2021.100998
|
[43]
|
Zhang, Z., Huang, R. and Lai, Y. (2023) Expression Signature of Ten Small Nuclear RNAs Serves as Novel Biomarker for Prognosis Prediction of Acute Myeloid Leukemia. Scientific Reports, 13, Article No. 18489. https://doi.org/10.1038/s41598-023-45626-x
|